SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

$CLB
Oilfield Services/Equipment
Energy
Get the next $CLB alert in real time by email
SC 13G/A 1 d408856dsc13ga.htm CORE LABORATORIES NV Core Laboratories NV

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

 

 

Core Laboratories N.V.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

N22717107

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. N22717107

 

  1.    

  Names of Reporting Persons

 

  Alger Associates, Inc. 13-3017981

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☐

 

  3.    

  SEC Use Only

 

  4.    

  Citizenship or Place of Organization

 

  New York

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

    5.     

  Sole Voting Power

 

  2,931,203

  6.     

  Shared Voting Power

 

  0

  7.     

  Sole Dispositive Power

 

  3,853,977

  8.     

  Shared Dispositive Power

 

  0

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  3,853,977

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  8.3%

12.    

  Type of Reporting Person (See Instructions)

 

  HC

 

2


Item 1.    
  (a)   Name of Issuer
   

Core Laboratories N.V.

  (b)  

Address of Issuer’s Principal Executive Offices

Van Heuven Goedhartlaan 7B

1181 LE Amstelveen

The Netherlands

Item 2.    
  (a)   Name of Person Filing
   

Alger Associates, Inc.

  (b)   Address of Principal Business Office or, if none, Residence
   

100 Pearl Street, 27th Floor, New York, NY 10004

  (c)   Citizenship
   

New York

  (d)   Title of Class of Securities
   

Common Shares

  (e)   CUSIP Number
   

N22717107

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a)     Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
  (b)     Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c)     Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d)     Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e)     An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f)     An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g)     A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  (h)     A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)     A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j)     A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
  (k)     Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:                                                 

 

3


Item 4.        Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
   (a)    Amount beneficially owned:
     

3,853,977

   (b)    Percent of class:
     

8.3%

   (c)        Number of shares as to which the person has:
     

 

          (i)    Sole power to vote or to direct the vote
        

2,931,203

          (ii)    Shared power to vote or to direct the vote
        

0

          (iii)    Sole power to dispose or to direct the disposition of
        

3,853,977

          (iv)      Shared power to dispose or to direct the disposition of
        

0

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

The securities reported herein are beneficially owned by one or more open-end investment companies or other managed accounts that are investment management clients of Fred Alger Management, LLC (“FAM”), a registered investment adviser, and Weatherbie Capital, LLC (“WC”), a registered investment adviser. WC is a 100% owned subsidiary of Alger-Weatherbie Holdings, LLC (“AWH”), a holding company. Each of FAM and AWH is a 100% owned subsidiary of Alger Group Holdings, LLC (“AGH”), a holding company. AGH is a 100% owned subsidiary of Alger Associates, Inc., a holding company.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

See Exhibit A

 

Item 8.

Identification and Classification of Members of the Group

 

Item 9.

Notice of Dissolution of Group

 

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

4


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

By:   Alger Associates, Inc.
By:  

/s/ Hal Liebes

Name:   Hal Liebes
Title:   Secretary
Date:   February 14, 2023

 

5


Exhibit A

Subsidiary

Alger Group Holdings, LLC* — HC

Fred Alger Management, LLC — IA

Alger-Weatherbie Holdings, LLC* — HC

Weatherbie Capital, LLC* — IA

* Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.

Get the next $CLB alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLB

DatePrice TargetRatingAnalyst
3/12/2025$15.00 → $16.00Sell → Neutral
Citigroup
6/30/2023$22.00 → $21.00Neutral → Sell
Citigroup
4/18/2023$21.50Neutral → Underperform
BofA Securities
1/9/2023Underperform → Neutral
BofA Securities
10/7/2022$24.00 → $17.00Sell → Neutral
Citigroup
9/26/2022$20.00Equal-Weight → Underweight
Morgan Stanley
4/18/2022$19.50 → $21.30Neutral → Underweight
Piper Sandler
1/18/2022$32.00 → $30.00Equal-Weight
Morgan Stanley
More analyst ratings

$CLB
Press Releases

Fastest customizable press release news feed in the world

See more
  • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

    $CLB
    Oilfield Services/Equipment
    Energy
  • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

    FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

    $CLB
    Oilfield Services/Equipment
    Energy
  • CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025.   Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results.  An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call.  For those not available to listen to the live webcast, a

    $CLB
    Oilfield Services/Equipment
    Energy

$CLB
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CLB
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CLB
SEC Filings

See more

$CLB
Financials

Live finance-specific insights

See more
  • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

    $CLB
    Oilfield Services/Equipment
    Energy
  • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

    FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

    $CLB
    Oilfield Services/Equipment
    Energy
  • CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025.   Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results.  An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call.  For those not available to listen to the live webcast, a

    $CLB
    Oilfield Services/Equipment
    Energy

$CLB
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more